PharmacyCodes



Salutensin-Demi en es it fr

Salutensin-Demi Brand names, Salutensin-Demi Analogs

Salutensin-Demi Brand Names Mixture

  • Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
  • Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
  • SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)

Salutensin-Demi Chemical_Formula

C33H40N2O9

Salutensin-Demi RX_link

No information avaliable

Salutensin-Demi fda sheet

Salutensin-Demi msds (material safety sheet)

Salutensin-Demi MSDS

Salutensin-Demi Synthesis Reference

No information avaliable

Salutensin-Demi Molecular Weight

608.679 g/mol

Salutensin-Demi Melting Point

264.5 oC

Salutensin-Demi H2O Solubility

73 mg/L

Salutensin-Demi State

Solid

Salutensin-Demi LogP

3.32

Salutensin-Demi Dosage Forms

Tablets

Salutensin-Demi Indication

Foe the treatment of hypertension

Salutensin-Demi Pharmacology

Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.

Salutensin-Demi Absorption

No information avaliable

Salutensin-Demi side effects and Toxicity

Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg

Salutensin-Demi Patient Information

No information avaliable

Salutensin-Demi Organisms Affected

Humans and other mammals